Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 6 | 2020 | 647 | 0.700 |
Why?
|
| Glioma | 3 | 2018 | 136 | 0.550 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2017 | 384 | 0.340 |
Why?
|
| Glioblastoma | 3 | 2020 | 157 | 0.330 |
Why?
|
| Skin Neoplasms | 2 | 2004 | 217 | 0.330 |
Why?
|
| Mixed Tumor, Mesodermal | 1 | 2010 | 2 | 0.330 |
Why?
|
| Neuroectodermal Tumors | 1 | 2010 | 2 | 0.330 |
Why?
|
| Microvessels | 1 | 2009 | 28 | 0.310 |
Why?
|
| Temporal Lobe | 1 | 2009 | 30 | 0.310 |
Why?
|
| Immunohistochemistry | 6 | 2010 | 497 | 0.300 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2020 | 44 | 0.300 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 103 | 0.300 |
Why?
|
| Astrocytoma | 2 | 2010 | 29 | 0.290 |
Why?
|
| Hippocampus | 1 | 2009 | 171 | 0.280 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 14 | 0.280 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2008 | 20 | 0.280 |
Why?
|
| Brain | 2 | 2005 | 946 | 0.280 |
Why?
|
| Chromosome Aberrations | 1 | 2008 | 23 | 0.280 |
Why?
|
| Brain Chemistry | 1 | 2005 | 29 | 0.230 |
Why?
|
| Neurons | 2 | 2009 | 416 | 0.230 |
Why?
|
| Humans | 26 | 2020 | 32814 | 0.220 |
Why?
|
| Meningeal Neoplasms | 2 | 2017 | 50 | 0.220 |
Why?
|
| Meningioma | 2 | 2017 | 58 | 0.220 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2004 | 5 | 0.220 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2018 | 158 | 0.220 |
Why?
|
| Lectins | 1 | 2004 | 11 | 0.220 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 36 | 0.210 |
Why?
|
| Cell Communication | 1 | 2004 | 29 | 0.210 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2004 | 9 | 0.210 |
Why?
|
| Middle Aged | 13 | 2018 | 12133 | 0.210 |
Why?
|
| Antigens, CD | 1 | 2004 | 101 | 0.210 |
Why?
|
| Microglia | 1 | 2004 | 68 | 0.200 |
Why?
|
| Sulfones | 2 | 2020 | 20 | 0.200 |
Why?
|
| Indans | 2 | 2020 | 34 | 0.200 |
Why?
|
| Cytokines | 1 | 2004 | 247 | 0.190 |
Why?
|
| Hyperplasia | 1 | 2002 | 39 | 0.190 |
Why?
|
| Dementia | 1 | 2005 | 245 | 0.190 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 302 | 0.180 |
Why?
|
| Female | 16 | 2018 | 20271 | 0.180 |
Why?
|
| Melanoma | 1 | 2002 | 165 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2013 | 59 | 0.170 |
Why?
|
| Aged | 10 | 2018 | 10544 | 0.160 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2018 | 5 | 0.140 |
Why?
|
| Genomics | 1 | 2018 | 88 | 0.140 |
Why?
|
| Tumor Burden | 1 | 2017 | 61 | 0.130 |
Why?
|
| Eye Evisceration | 1 | 2017 | 1 | 0.130 |
Why?
|
| Acrylic Resins | 1 | 2017 | 3 | 0.130 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2017 | 80 | 0.130 |
Why?
|
| Survival Rate | 3 | 2018 | 894 | 0.130 |
Why?
|
| Orbital Implants | 1 | 2017 | 3 | 0.130 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 39 | 0.130 |
Why?
|
| Orbit | 1 | 2017 | 19 | 0.130 |
Why?
|
| Adult | 8 | 2017 | 9569 | 0.130 |
Why?
|
| Genome, Human | 1 | 2017 | 132 | 0.130 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 145 | 0.130 |
Why?
|
| Hydrogels | 1 | 2017 | 126 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2018 | 1307 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 599 | 0.120 |
Why?
|
| Biocompatible Materials | 1 | 2017 | 233 | 0.120 |
Why?
|
| Male | 12 | 2018 | 19650 | 0.120 |
Why?
|
| Ganglioglioma | 1 | 2015 | 6 | 0.110 |
Why?
|
| Models, Biological | 2 | 2008 | 392 | 0.110 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 4034 | 0.100 |
Why?
|
| Epidermal Cyst | 1 | 2013 | 4 | 0.100 |
Why?
|
| Cyclin D1 | 1 | 2013 | 14 | 0.100 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2013 | 12 | 0.100 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2013 | 27 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2013 | 176 | 0.090 |
Why?
|
| Lung Neoplasms | 2 | 2008 | 429 | 0.090 |
Why?
|
| Nitrogen Mustard Compounds | 1 | 2012 | 4 | 0.090 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2012 | 22 | 0.090 |
Why?
|
| Disease Progression | 2 | 2018 | 594 | 0.090 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2012 | 40 | 0.090 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2012 | 29 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 526 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 754 | 0.090 |
Why?
|
| Prognosis | 3 | 2018 | 1545 | 0.090 |
Why?
|
| Medulloblastoma | 1 | 2010 | 7 | 0.080 |
Why?
|
| Cerebellar Neoplasms | 1 | 2010 | 11 | 0.080 |
Why?
|
| Ependymoma | 1 | 2010 | 4 | 0.080 |
Why?
|
| Ploidies | 1 | 2010 | 7 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 37 | 0.080 |
Why?
|
| Radiotherapy | 1 | 2010 | 82 | 0.080 |
Why?
|
| Frontal Lobe | 1 | 2010 | 37 | 0.080 |
Why?
|
| DNA, Neoplasm | 1 | 2010 | 54 | 0.080 |
Why?
|
| Esophagitis | 1 | 2009 | 5 | 0.080 |
Why?
|
| Mice | 3 | 2020 | 2512 | 0.080 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2009 | 1 | 0.080 |
Why?
|
| Eosinophilia | 1 | 2009 | 11 | 0.080 |
Why?
|
| Collagen Type IV | 1 | 2009 | 9 | 0.080 |
Why?
|
| Radial Neuropathy | 1 | 2009 | 11 | 0.080 |
Why?
|
| Sclerosis | 1 | 2009 | 10 | 0.080 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2009 | 15 | 0.080 |
Why?
|
| Radial Nerve | 1 | 2009 | 17 | 0.080 |
Why?
|
| Alkaline Phosphatase | 1 | 2009 | 33 | 0.080 |
Why?
|
| Cell Death | 1 | 2009 | 71 | 0.080 |
Why?
|
| Animals | 5 | 2020 | 7570 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2009 | 29 | 0.080 |
Why?
|
| Migraine Disorders | 1 | 2010 | 69 | 0.080 |
Why?
|
| Intestines | 1 | 2009 | 60 | 0.080 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2009 | 8 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2009 | 70 | 0.080 |
Why?
|
| Neural Conduction | 1 | 2009 | 89 | 0.080 |
Why?
|
| Spinal Nerves | 1 | 2009 | 65 | 0.070 |
Why?
|
| Radiosurgery | 1 | 2012 | 362 | 0.070 |
Why?
|
| Hemangioma, Capillary | 1 | 2008 | 3 | 0.070 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2008 | 11 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2008 | 8 | 0.070 |
Why?
|
| Aneuploidy | 1 | 2008 | 11 | 0.070 |
Why?
|
| Monosomy | 1 | 2008 | 5 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2008 | 15 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 42 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2010 | 468 | 0.070 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 193 | 0.070 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2005 | 1 | 0.060 |
Why?
|
| Neurofibrillary Tangles | 1 | 2005 | 4 | 0.060 |
Why?
|
| tau Proteins | 1 | 2005 | 39 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2005 | 87 | 0.060 |
Why?
|
| Base Sequence | 1 | 2005 | 247 | 0.060 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2005 | 28 | 0.050 |
Why?
|
| Age Factors | 1 | 2008 | 1197 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2005 | 287 | 0.050 |
Why?
|
| Child | 3 | 2017 | 2478 | 0.050 |
Why?
|
| Feedback, Physiological | 1 | 2004 | 10 | 0.050 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 326 | 0.050 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2004 | 2 | 0.050 |
Why?
|
| Keratin-20 | 1 | 2004 | 5 | 0.050 |
Why?
|
| Intermediate Filament Proteins | 1 | 2004 | 11 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2004 | 10 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2004 | 47 | 0.050 |
Why?
|
| Ligands | 1 | 2004 | 78 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 50 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2005 | 459 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2004 | 80 | 0.050 |
Why?
|
| Presynaptic Terminals | 1 | 2004 | 37 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 115 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2004 | 169 | 0.050 |
Why?
|
| Genotype | 1 | 2005 | 731 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2004 | 288 | 0.050 |
Why?
|
| Aging | 1 | 2009 | 938 | 0.050 |
Why?
|
| Mutation | 2 | 2017 | 493 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 213 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2004 | 498 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 622 | 0.050 |
Why?
|
| Adolescent | 2 | 2017 | 3640 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2004 | 820 | 0.050 |
Why?
|
| Macrophages | 1 | 2002 | 194 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 115 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2020 | 290 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 172 | 0.040 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2018 | 12 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 727 | 0.040 |
Why?
|
| RNA Interference | 1 | 2018 | 77 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2020 | 603 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 113 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 72 | 0.030 |
Why?
|
| DNA Repair | 1 | 2017 | 57 | 0.030 |
Why?
|
| Injections | 1 | 2017 | 63 | 0.030 |
Why?
|
| Rabbits | 1 | 2017 | 192 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2017 | 3705 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2015 | 134 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2010 | 949 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 1083 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2013 | 4 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 1282 | 0.030 |
Why?
|
| G2 Phase | 1 | 2013 | 17 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 471 | 0.030 |
Why?
|
| Mitosis | 1 | 2013 | 24 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 24 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 563 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1012 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2013 | 44 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2013 | 3441 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2013 | 114 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 258 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 208 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 220 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 265 | 0.020 |
Why?
|
| Radiometry | 1 | 2012 | 40 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 156 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 362 | 0.020 |
Why?
|
| Craniopharyngioma | 1 | 2010 | 8 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2010 | 41 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 35 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 2010 | 17 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2009 | 11 | 0.020 |
Why?
|
| Vasculitis | 1 | 2009 | 24 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 2009 | 19 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 2009 | 52 | 0.020 |
Why?
|
| Sarcoidosis | 1 | 2009 | 32 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2008 | 21 | 0.020 |
Why?
|
| Pneumonectomy | 1 | 2008 | 14 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2008 | 25 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 90 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 381 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2008 | 694 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 881 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 2285 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2008 | 1461 | 0.010 |
Why?
|